FRA:DMP • DE000A2GS5D8
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DERMAPHARM HOLDING SE (DMP.DE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-07 | Berenberg | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.135B 10.79% | 1.181B 4.00% | 1.165B -1.34% | 1.229B 5.50% | 1.275B 3.74% | 1.316B 3.22% | 1.387B 5.40% | 1.45B 4.54% | 1.446B -0.28% | 1.496B 3.46% | 1.548B 3.48% | |
| EBITDA YoY % growth | 302.764M -19.98% | 314.578M 3.90% | 336.121M 6.85% | 347.58M 3.41% | 365.54M 5.17% | 382.45M 4.63% | 348.38M -8.91% | 358.34M 2.86% | N/A | N/A | N/A | |
| EBIT YoY % growth | 200.992M -29.09% | 227.793M 13.33% | 244.111M 7.16% | 249.67M 2.28% | 263.29M 5.46% | 295.81M 12.35% | 276.38M -6.57% | 286.06M 3.50% | 295.93M 3.45% | 306.3M 3.50% | 316.86M 3.45% | |
| Operating Margin | 17.70% | 19.29% | 20.95% | 20.31% | 20.65% | 22.48% | 19.93% | 19.73% | 20.47% | 20.47% | 20.47% | |
| EPS YoY % growth | N/A -36.10% | N/A -8.62% | N/A 11.41% | 2.47 8.33% | 2.70 9.49% | 3.33 23.32% | N/A | N/A | N/A | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
11 analysts have analysed DMP.DE and the average price target is 41.82 EUR. This implies a price decrease of -8.29% is expected in the next year compared to the current price of 45.6.
DERMAPHARM HOLDING SE (DMP.DE) will report earnings on 2026-05-13.
The consensus rating for DERMAPHARM HOLDING SE (DMP.DE) is 78.1818 / 100 . This indicates that analysts generally have a positive outlook on the stock.